NPPA asks Bayer Zydus Pharma to continue selling Urografin for one more year: Gireesh Babu, New Delhi Saturday, March 29, 2025, 08:00 Hrs [IST] The National Pharmaceutical Pricing ...

The "Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering. In the progressive ...

Hua Medicine Announces 2024 Annual Results - HuaTangNing completed its first full year for reimbursement under the National Reimbursement D ...

The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...

Annual Report/MiscellaneousMEDICLIN ends successful 2024 financial year 28.03.2025 / 10:24 CET/CESTThe issuer is solely responsible for the content of this announcement.Offenburg, March 28, ...

OncoZenge AB (publ) (“OncoZenge” or the “Company”) announces that the Company has entered into a binding agreement to partner with L. Molteni & C. dei F.lli Alitti, Società di Esercizio S.p.A ...

Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and ...

The survey predicted the increase would happen within the next six months. Other industry news is on health care access in rural areas; Pfizer's alleged attempt to avoid taxes; and more.

Automating sales order processing isn’t just about efficiency—it’s about positioning your business for future success.

Tuspetinib Triple Drug Frontline Therapy Advancing in TUSCANY Clinical Trial Results to Date Highlight TUS Potential as an ...

We think SPH is in a good financial position. In the past three years, its debt over capital has been stable at around 0.4 times. Despite not being in a net cash position, it has enough cash to ...

Leah Jackson is the forward-thinking, innovative group director of commerce strategy at GroupM. In her role, Jackson ...